Praxis Precision Medicines, Inc. (PRAX)
NASDAQ: PRAX · Real-Time Price · USD
319.57
+13.95 (4.56%)
At close: Feb 6, 2026, 4:00 PM EST
319.70
+0.13 (0.04%)
After-hours: Feb 6, 2026, 7:53 PM EST
PRAX Market Cap
PRAX has a market cap or net worth of $8.86 billion as of February 6, 2026. Its market cap has increased by 493.46% in one year.
Market Cap
8.86B
Enterprise Value
8.48B
1-Year Change
493.46%
Ranking
Category
Stock Price
$319.57
Market Cap Chart
Since the IPO on October 16, 2020, PRAX's market cap has increased from $698.02M to $8.86B, an increase of 1,169.95%. That is a compound annual growth rate of 61.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 6, 2026 | 8.86B | 20.27% |
| Dec 31, 2025 | 7.37B | 397.55% |
| Dec 31, 2024 | 1.48B | 675.84% |
| Dec 29, 2023 | 190.94M | 70.27% |
| Dec 30, 2022 | 112.14M | -87.31% |
| Dec 31, 2021 | 883.49M | -58.02% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Madrigal Pharmaceuticals | 10.85B |
| Bio-Techne | 10.45B |
| Jazz Pharmaceuticals | 10.06B |
| Halozyme Therapeutics | 9.55B |
| Axsome Therapeutics | 9.20B |
| Arrowhead Pharmaceuticals | 9.03B |
| ABIVAX Société Anonyme | 8.91B |
| Vaxcyte | 8.06B |